A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers

Journal:

Nature Communications

Published:

2025-08-15

DOI:

10.1038/s41467-025-62979-1

Affiliations:

8

Authors:

33

Go to article

Institutions	Authors	Share
Children's Hospital of Philadelphia (CHOP), United States of America (USA)	22.000000 22.000000 22.000000	0.67
Health Sciences, Pitt, United States of America (USA)	4.000000	0.12
University of Pennsylvania (Penn), United States of America (USA)	3.000000	0.09
Sant'Orsola Malpighi Hospital, Italy	1.500000	0.05
Celldex Therapeutics, Inc., United States of America (USA)	1.000000	0.03
Center for Computational and Genomic Medicine, CHOP, United States of America (USA)	1.000000	0.03
University of Bologna (UNIBO), Italy	0.500000	0.02

Interested in Oncology and Carcinogenesis?